Proof-of-principle that a decoy virus protects oncolytic measles virus against neutralizing antibodies

BACKGROUND: Attenuated oncolytic measles virus (OMV) is a promising antitumor agent in early-phase clinical trials. However, pre-existing immunity against measles might be a hurdle for OMV therapy. METHODS: OMV was inactivated with short-wavelength ultraviolet light (UV-C). Loss of replication and o...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncolytic Virother
Asıl Yazarlar: Xu, Chun, Goß, Annika Verena, Dorneburg, Carmen, Debatin, Klaus-Michael, Wei, Jiwu, Beltinger, Christian
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Dove Medical Press 2018
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5933358/
https://ncbi.nlm.nih.gov/pubmed/29750140
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OV.S150637
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller